SCHEMBL7403003

SCHEMBL7403003

NCCn1[c]ncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3556724 0.62
SCHEMBL8625860 0.59
SCHEMBL174331 0.55
SCHEMBL16050529 0.54
SCHEMBL855088 0.54
SCHEMBL4505762 0.49
Ethylenediamine SCHEMBL29210069 0.46 HSP90AA1 (0.33)
Ethylenediamine SCHEMBL37647 0.39
Ethylenediamine SCHEMBL30253568 0.39
Ethylenediamine SCHEMBL7085968 0.39 NFKB1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235829-A2 PYRAZOLO 1,5-D] 1,2,4]TRIAZINES FOR ENHANCING COGNITION MERCK SHARP &amp; DOHME LTD. (GB) 2002-09-04 EP disclosed
US-6355638-B1 COGNITION ACTIVATORS MERCK SHARP & DOHME LTD. (GB) 2002-03-12 US disclosed
WO-2001038331-A2 PYRAZOLO[1,5-D][1,2,4]TRIAZINES FOR ENHANCING COGNITION MERCK SHARP & DOHME LIMITED (GB) 2001-05-31 WO disclosed